Skip to main content
Tech.euFundingExplorerBeta

SeaBeLife

SeaBeLife is a biotechnology company that develops small molecules designed to block regulated cell death pathways to treat acute, rare, and chronic diseases.

SeaBeLife has raised €6.1M across 4 funding rounds from 5 investors, most recently a Seed round in Oct 2025. Based in Roscoff, France; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€6.1M
€6,070,000
Funding rounds
4
Investors
5
distinct backers
Active since
2022-03
latest 2025-10

Funding by year

EUR raised per year
SeaBeLife — funding by year — interactive chart.
Data table
SeaBeLife — funding by year
2022€1.4M
2023€1.2M
2024€1.5M
2025€2.0M

Signals

High confidence
Raise-next likelihood69
base rate 44% for Seed
  • ▲ In typical raise window
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood18
base rate 11% (2+ rounds)
  • ▲ 4 rounds raised
  • ▲ Recently backed by strong-exit-track investors

Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

4 rounds
DateStageAmountInvestors
2025-10-01Seed€2.0MiXLife,Femmes Business Angels,INextView deal →
2024-04-22Grant€1.5Mi-Nov 2024 innovation competitionView deal →
2023-09-27Other€1.2MiXLifeView deal →
2022-03-14Other€1.4MBpifranceView deal →

Similar companies

same sector or country

Global coverage: FundingData